These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26205145)

  • 1. Insights into the clinical value of cyclin-dependent kinase 5 in glioma: a retrospective study.
    Yushan R; Wenjie C; Suning H; Yiwu D; Tengfei Z; Madushi WM; Feifei L; Changwen Z; Xin W; Roodrajeetsing G; Zuyun L; Gang C
    World J Surg Oncol; 2015 Jul; 13():223. PubMed ID: 26205145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
    Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G
    World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between miR-218 and CDK6 expression and their biological impact on glioma cell proliferation and apoptosis].
    Zhang JM; Sun CY; Yu SZ; Wang Q; An TL; Li YY; Kong YL; Wen YJ
    Zhonghua Bing Li Xue Za Zhi; 2011 Jul; 40(7):454-9. PubMed ID: 22088371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cyclinD1 and Ki-67 proteins in gliomas and its clinical significance.
    Qu DW; Xu HS; Han XJ; Wang YL; Ouyang CJ
    Eur Rev Med Pharmacol Sci; 2014; 18(4):516-9. PubMed ID: 24610618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slit2 and Robo1 expression as biomarkers for assessing prognosis in brain glioma patients.
    Liu L; Li W; Geng S; Fang Y; Sun Z; Hu H; Liang Z; Yan Z
    Surg Oncol; 2016 Dec; 25(4):405-410. PubMed ID: 27916173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulated expression of cry1 and cry2 in human gliomas.
    Luo Y; Wang F; Chen LA; Chen XW; Chen ZJ; Liu PF; li FF; Li CY; Liang W
    Asian Pac J Cancer Prev; 2012; 13(11):5725-8. PubMed ID: 23317246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
    Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH
    Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of 4'-[methyl-(11)C]-thiothymidine uptake with Ki-67 immunohistochemistry and tumor grade in patients with newly diagnosed gliomas in comparison with (11)C-methionine uptake.
    Tanaka K; Yamamoto Y; Maeda Y; Yamamoto H; Kudomi N; Kawai N; Toyohara J; Nishiyama Y
    Ann Nucl Med; 2016 Feb; 30(2):89-96. PubMed ID: 26511019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and prognostic value of the WEE1 kinase in gliomas.
    Music D; Dahlrot RH; Hermansen SK; Hjelmborg J; de Stricker K; Hansen S; Kristensen BW
    J Neurooncol; 2016 Apr; 127(2):381-9. PubMed ID: 26738845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Ki-67 Labeling index and Histopathological Grading of Glioma in Indonesian Population.
    Theresia E; Malueka RG; Pranacipta S; Kameswari B; Dananjoyo K; Asmedi A; Wicaksono AS; Hartanto RA; Dwianingsih EK
    Asian Pac J Cancer Prev; 2020 Apr; 21(4):1063-1068. PubMed ID: 32334471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas.
    Tsai WC; Hueng DY; Lin CR; Yang TC; Gao HW
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-584-3p, a novel tumor suppressor and prognostic marker, reduces the migration and invasion of human glioma cells by targeting hypoxia-induced ROCK1.
    Xue H; Guo X; Han X; Yan S; Zhang J; Xu S; Li T; Guo X; Zhang P; Gao X; Liu Q; Li G
    Oncotarget; 2016 Jan; 7(4):4785-805. PubMed ID: 26715733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Roundabout4 predicts poor prognosis of primary glioma patients via correlating with microvessel density.
    Cai H; Xue Y; Liu W; Li Z; Hu Y; Li Z; Shang X; Liu Y
    J Neurooncol; 2015 May; 123(1):161-9. PubMed ID: 25859844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma.
    He J; Deng Y; Yang G; Xie W
    J Surg Oncol; 2013 Aug; 108(2):121-5. PubMed ID: 23813496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of programmed cell death-ligand 1 and its correlation with clinical outcomes in gliomas.
    Zeng J; Zhang XK; Chen HD; Zhong ZH; Wu QL; Lin SX
    Oncotarget; 2016 Feb; 7(8):8944-55. PubMed ID: 26771840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The correlation of bone morphogenetic protein 2 with poor prognosis in glioma patients.
    Yang X; Li D; Cheng S; Fan K; Sheng L; Zhang J; Feng B; Xu Z
    Tumour Biol; 2014 Nov; 35(11):11091-5. PubMed ID: 25099618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gab2 expression in glioma and its implications for tumor invasion.
    Shi L; Sun X; Zhang J; Zhao C; Li H; Liu Z; Fang C; Wang X; Zhao C; Zhang X; Zhou F; Lu S; Luo R; Zhang B
    Acta Oncol; 2013 Nov; 52(8):1739-50. PubMed ID: 23231021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of SALL4 in patients with gliomas: high level of SALL4 expression is correlated with poor outcome.
    Zhang L; Yan Y; Jiang Y; Cui Y; Zou Y; Qian J; Luo C; Lu Y; Wu X
    J Neurooncol; 2015 Jan; 121(2):261-8. PubMed ID: 25359397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of CCL20 and its receptor CCR6 predicts poor clinical prognosis in human gliomas.
    Wang L; Qin H; Li L; Zhang Y; Tu Y; Feng F; Ji P; Zhang J; Li G; Zhao Z; Gao G
    Med Oncol; 2012 Dec; 29(5):3491-7. PubMed ID: 22926920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas.
    Wu X; Wu F; Xu D; Zhang T
    J Neurooncol; 2016 Apr; 127(2):221-32. PubMed ID: 26757925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.